Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Shchinova

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemistry. Biokhimiia|September 14, 2018
Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)T I Arefieva, A Yu Filatova, A V Potekhina, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting]A M Shchinova, G V Shlevkova, A Y Filatova, et al.
Kardiologiia|February 2, 2019
A Yu Filatova, M V Vitsenya, A V Potekhina, et al.
Kardiologiia|November 6, 2020
[The prognostic value of high-sensitivity C-reactive protein blood level after coronary stenting for the development of stent restenosis]A Yu Filatova, G V Shlevkova, A V Potekhina, et al.
Terapevticheskii Arkhiv|March 15, 2021
[Analysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris]A Y Filatova, A K Osokina, A V Potekhina, et al.
Bulletin of Experimental Biology and Medicine|January 11, 2019
Low Blood Content of IL-10-Producing CD4<sup>+</sup> T Cells as a Risk Factor for Progression of Coronary AtherosclerosisA Yu Filatova, E A Pylaeva, A V Potekhina, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemistry. Biokhimiia|September 14, 2018
Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)T I Arefieva, A Yu Filatova, A V Potekhina, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting]A M Shchinova, G V Shlevkova, A Y Filatova, et al.
Kardiologiia|February 2, 2019
A Yu Filatova, M V Vitsenya, A V Potekhina, et al.
Kardiologiia|November 6, 2020
[The prognostic value of high-sensitivity C-reactive protein blood level after coronary stenting for the development of stent restenosis]A Yu Filatova, G V Shlevkova, A V Potekhina, et al.
Terapevticheskii Arkhiv|March 15, 2021
[Analysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris]A Y Filatova, A K Osokina, A V Potekhina, et al.
Bulletin of Experimental Biology and Medicine|January 11, 2019
Low Blood Content of IL-10-Producing CD4<sup>+</sup> T Cells as a Risk Factor for Progression of Coronary AtherosclerosisA Yu Filatova, E A Pylaeva, A V Potekhina, et al.
Pageof 1